Ingenium Analytics | André Bakhos @IngeniumMkts

When the Chart Disagrees With Itself A constructive pattern can form while the evidence beneath it is deteriorating. Momentum may be fading, breadth narrowing, and divergences developing even while price still looks intact. That does not automatically invalidate the pattern. It changes how much risk should be committed to it. The pattern identifies the opportunity. The supporting evidence determines its quality. If the structure triggers while the internals remain conflicted, partial exposure may be appropriate. If price follows through and the internals improve, add. If price fails while divergences deepen, the conflict itself becomes the message. Price gets the vote. Indicators set the risk budget. Divergence tells us when that vote deserves closer scrutiny. #TechnicalAnalysis #MarketStrategy #RiskManagement #IngeniumAnalytics

The S&P 500 versus Equal Weight ratio is testing the highest level in more than 23 years of live Equal Weight history. The capitalization-weighted index has rarely been this dominant. This is an extraordinary measure of concentrated leadership: the index continues to advance, but an increasingly disproportionate share of that performance is coming from its largest constituents, confirming what many traditional breadth measures and our own Breadth Engine work have been showing. By itself, however, this is not a bearish signal. Concentration is a condition, not a timing tool, and these regimes can persist for extended periods. The significance is that a progressively narrower group of stocks is driving headline index strength. $SPX #SP500 #MarketBreadth #TechnicalAnalysis #Stocks

Weak breadth is no secret. Our Bull Breadth Engine currently registers just 77 names. Of those: XLK: 30 XLV: 22 That means Technology and Health Care account for 52 of 77 Bull names — roughly 68%. In many respects, we have three markets right now: the S&P 500, Technology, and Health Care. The negative divergence remains. Tread carefully.

The market continues to defy its own internals. Our SPX Bull & Bear Breadth Engine now shows: Bears: 299 Bulls: 90 In late March, Bulls reached roughly 59 while Bears peaked near 374, around the market low. This time, we have seen nothing resembling that kind of price damage. The market remains near its highs even as participation continues to narrow. The equal-weight S&P 500 reinforces the message, telling a very different story from the cap-weighted index. Negative breadth divergence is a warning condition, not a timing signal. Price can continue higher, the internals can repair through time or broader participation, or price can eventually adjust lower to reflect the weakness already visible beneath the surface. For now: Price remains resilient. Breadth remains weak. The divergence remains unresolved. #SPX #SP500 #TechnicalAnalysis #MarketBreadth #MarketInternals

The deterioration in our Bull & Bear Breadth Engine has continued to deepen, yet the S&P 500 remains remarkably resilient near the highs. Bull breadth is weakening. Bear breadth is building. Price, so far, refuses to break. That leaves the market at an increasingly important inflection point: will the index finally resolve the divergence with an accelerated move lower, or will price hold long enough for breadth to recover and repair the damage? For now, the standoff continues. The index is holding. The internals are not. One of them will eventually give way. #TechnicalAnalysis #MarketBreadth #SP500 #MarketInternals #RiskManagement #IngeniumAnalytics

The market has a way of exposing what a trader truly wants, not merely what he says he wants. Discipline seeks returns. Ego often seeks validation. #Trading #Markets #BehavioralFinance #TradingPsychology #RiskManagement #EdSeykota

We see clear signs warranting attention from our Bull & Bear Breadth Engine. The S&P 500 remains near all-time highs, while erosion is creeping into the Bull factor in light blue and the Bear factor is beginning to accelerate in red. The recent negative divergence suggests that some weakness may be in the offing. Whether this is simply a seasonal exposure-reducing phase or the beginning of something more meaningful beneath the surface remains to be seen. What matters here is the growing disconnect between price and participation. The index remains near its highs, but the internal backdrop is becoming progressively less supportive. This does not yet look like wholesale trend deterioration. It does, however, look like a market where the internal margin for error is getting smaller. Price can continue higher under those conditions, but unless breadth begins to re-expand, we would treat further strength with increasing selectivity rather than increasing confidence. The indices are still near the highs. The internals are telling us not to get too comfortable. #TechnicalAnalysis #MarketBreadth #SP500 #MarketInternals #Equities #RiskManagement #IngeniumAnalytics

Divergence is one of the more useful concepts in market analysis, but it is also one of the most casually misused. A stock makes a new high, but an indicator does not. A sector breaks to a lower low, but a breadth measure refuses to confirm. Price advances, but participation fades underneath the surface. That can matter. But not every non-confirmation deserves to be called meaningful divergence. The first question should not be, “Is there a divergence?” The better question is, “Divergence against what, and over what timeframe?” A divergence against an untested, poorly understood, or loosely constructed indicator is often little more than chart decoration. It may look interesting, but looking interesting is not the same as carrying analytical weight. For divergence to matter, the reference point must matter. The indicator, model, breadth series, relative-strength measure, volume construct, or internal data set being used should have demonstrated value. It should reveal something price alone does not: participation, sponsorship, momentum persistence, demand/supply pressure, relative leadership, risk appetite, or internal deterioration. Timeframe also matters. A short-term divergence inside a longer-term uptrend may be nothing more than rotation, digestion, or a pause in sponsorship. A longer-term divergence against a major trend can carry a very different message. The analytical weight changes depending on whether the divergence is appearing on an intraday chart, a daily structure, a weekly trend, or across a broader market cycle. This is where discipline separates analysis from pattern hunting. A valid divergence is not simply an indicator failing to mimic price. It is a separation between surface behavior and internal condition, measured against a tool that has earned its seat at the table, across a timeframe that fits the decision being made. Even then, divergence is not a trade signal by itself. It is a condition. It is evidence. It is a warning flare, not a complete thesis. The mistake is treating every divergence as predictive. The more professional approach is to view it as a change in the quality of the move. Price may still be rising, but sponsorship may be thinning. Price may still be falling, but selling pressure may be losing force. The crowd sees the print; the analyst studies the condition behind the print. In markets, price is the final arbiter. But price does not always tell the whole story early enough. That is why valid divergence matters. Not because two lines disagree. But because a trusted measure, over a relevant timeframe, is telling us that the visible move and the underlying structure are no longer in full agreement. That is where the work begins. #TechnicalAnalysis #MarketBreadth #Marketstructure #Markets

$MRNA update to the July 2 post. MRNA has now extended sharply through the $62.55 level and is pressing toward the next marked resistance/target at $170.47, following positive Phase 3 INTerpath-001 melanoma data from Moderna and Merck. The important technical point: TRENDER never wavered during the pullback. The bullish profile stayed intact beneath the surface while price consolidated. With sizeable short interest in the name, forced covering appears to be part of the move. Not advice. Just structure. #MRNA #Moderna #Merck #Biotech #Melanoma #CancerVaccine #TechnicalAnalysis #TRENDER #ShortInterest #Trading

A prolonged bull market can teach investors a dangerous lesson: “The last time I worried, I was wrong.” Enough repetitions and caution begins to feel foolish. Dip-buying becomes reflexive. Confidence hardens into certainty. Risk gets discounted because recent experience keeps rewarding the same behavior. That is recency bias at work: turning a temporary market condition into a permanent expectation. #MarketPsychology #BehavioralFinance

A century later, the instruments have changed. The crowd hasn’t. The pursuit of easy money remains one of the most durable features of market psychology. #MarketPsychology #BehavioralFinance #Trading #JesseLivermore #technicalanalysis

After enough market cycles spent on trading desks, where risk is real and time is unforgiving, one truth becomes unavoidable: technology evolves, instruments change, and market structure mutates—but human behavior does not. And because price is ultimately the expression of that behavior, the tape remains remarkably consistent across cycles. Real success in this business has never come from the most elaborate algorithm or the cleverest macro narrative. It comes from psychological discipline—the ability to respect trend, breadth, risk, and time when the crowd becomes emotional, overconfident, or loses its bearings. Indicators are only useful if the operator understands what they are actually measuring: behavior under pressure. Over decades and multiple market cycles, we have distilled the principles that consistently matter. They were not learned merely from textbooks or backtests, but through repetition across bull markets, bear markets, crashes, corrections, and long stretches of frustration. These are not slogans. They are operating maxims that align remarkably well with what disciplined technical analysis reveals once the noise is stripped away. Perhaps the most dangerous violation is pride of opinion. Behavioral finance has simply given academic language to what generations of traders already understood: ego is the enemy of P&L. Whether managing institutional flow or proprietary risk, disciplined respect for trend, internal participation, risk, and time—not prediction—is what separates professionals from tourists. The charts don’t care what we believe. They record what market participants are actually doing—and they do so with brutal honesty. #TechnicalAnalysis #BehavioralFinance #MarketStructure #RiskManagement #MarketBreadth #tradingPsychology #TrendFollowing #WallStreet #trading

Patience is not passivity. It is discipline. The market does not reward the analyst who predicts first. It rewards the one who waits for the evidence, respects confirmation, and acts when the weight of the data supports the call. “Patience, patience, and more patience—that is the key to success. Without market confirmation, do not make predictions or take action.” — Jesse Livermore Confirmation first. Conviction second. Action last. #TechnicalAnalysis #MarketStrategy #TrendFollowing #BehavioralFinance #RiskManagement

@EdricCassian Good eye on the timing, though this is not standard RSI. TRENDER is a proprietary trend/momentum measure I use to identify when pressure is shifting beneath the surface. The improvement there helped confirm the developing price structure before the breakout through $62.55.

$MRNA update to the Jun 17 post. MRNA has traded through the $62.55 resistance level and has continued higher, aided by elevated short interest, a constructive Science Day/pipeline update, and a positive chart structure. The stock is now pressing into relative new territory, with the next target/resistance levels marked on the chart. Not advice. Just structure. #MRNA #Moderna #Biotech #TechnicalAnalysis #ShortInterest #Trading #MarketStructure

Track records are curated memories. The calls that aged badly get quietly buried. That often tells you more about the analyst than the calls that aged well. #Markets #TechnicalAnalysis #BehavioralFinance #RiskManagement

All Mag7 stocks now find themselves in negative daily trends as measured by the TRENDER. $NVDA, $AAPL, and $GOOGL remain positive on the weekly TRENDER, so this is not yet a complete breakdown in longer-term leadership. But with the $SPX now breaking its own daily TRENDER, the setup has become more fragile. Our Breadth Engine has improved, which suggests rotation beneath the surface. The issue is whether that improvement can mature into real leadership quickly enough to offset weakness in both the index and the former generals. At this stage, I would call it a warning, not a verdict. The market needs breadth to become leadership. Otherwise, rotation may not be enough. #Markets #TechnicalAnalysis #SPX #Mag7 #MarketBreadth #SectorRotation #TrendFollowing #Equities #Trading #MarketLeadership